JP2021513972A5 - - Google Patents
Info
- Publication number
- JP2021513972A5 JP2021513972A5 JP2020543492A JP2020543492A JP2021513972A5 JP 2021513972 A5 JP2021513972 A5 JP 2021513972A5 JP 2020543492 A JP2020543492 A JP 2020543492A JP 2020543492 A JP2020543492 A JP 2020543492A JP 2021513972 A5 JP2021513972 A5 JP 2021513972A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- tic
- speech
- social
- therapeutic
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023198772A JP2024023383A (ja) | 2018-02-16 | 2023-11-24 | 社会的機能障害の治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862761253P | 2018-02-16 | 2018-02-16 | |
| US62/761,253 | 2018-02-16 | ||
| PCT/US2019/018263 WO2019161236A1 (en) | 2018-02-16 | 2019-02-15 | Methods of treating social function disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023198772A Division JP2024023383A (ja) | 2018-02-16 | 2023-11-24 | 社会的機能障害の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021513972A JP2021513972A (ja) | 2021-06-03 |
| JP2021513972A5 true JP2021513972A5 (https=) | 2022-02-15 |
| JPWO2019161236A5 JPWO2019161236A5 (https=) | 2022-02-15 |
Family
ID=65529920
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543492A Pending JP2021513972A (ja) | 2018-02-16 | 2019-02-15 | 社会的機能障害の治療方法 |
| JP2023198772A Pending JP2024023383A (ja) | 2018-02-16 | 2023-11-24 | 社会的機能障害の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023198772A Pending JP2024023383A (ja) | 2018-02-16 | 2023-11-24 | 社会的機能障害の治療方法 |
Country Status (3)
| Country | Link |
|---|---|
| US (3) | US20210008030A1 (https=) |
| JP (2) | JP2021513972A (https=) |
| WO (1) | WO2019161236A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106883246B (zh) | 2009-12-04 | 2020-05-29 | 桑诺维恩药品公司 | 多环化合物及其使用方法 |
| CA3032141A1 (en) | 2016-07-29 | 2018-02-01 | Vadim ALEXANDROV | Compounds and compositions and uses thereof |
| IL268694B2 (en) | 2017-02-16 | 2023-10-01 | Sunovion Pharmaceuticals Inc | Treatment of schizophrenia |
| BR112020001433A2 (pt) | 2017-08-02 | 2020-07-28 | Sunovion Pharmaceuticals Inc. | compostos de isocromano e usos dos mesmos |
| EA202091945A1 (ru) | 2018-02-16 | 2021-01-18 | Суновион Фармасьютикалз Инк. | Соли, кристаллические формы и способы их получения |
| CN118576586A (zh) * | 2018-12-06 | 2024-09-03 | 住友制药美国公司 | 治疗神经和精神疾病的方法 |
| CN115734785A (zh) | 2020-04-14 | 2023-03-03 | 桑诺维恩药品公司 | (S)-(4,5-二氢-7H-噻吩并[2,3-c]吡喃-7-基)-N-甲基甲胺用于治疗神经和精神方面的病症 |
| WO2023049721A1 (en) | 2021-09-23 | 2023-03-30 | Sunovion Pharmaceuticals Inc. | Methods of treating metabolic disorders |
| TW202600129A (zh) * | 2024-02-23 | 2026-01-01 | 美商住友製藥美國公司 | 烏洛托隆（ulotaront）鹽酸鹽的製造方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| CN106883246B (zh) | 2009-12-04 | 2020-05-29 | 桑诺维恩药品公司 | 多环化合物及其使用方法 |
| IL268694B2 (en) * | 2017-02-16 | 2023-10-01 | Sunovion Pharmaceuticals Inc | Treatment of schizophrenia |
-
2019
- 2019-02-15 JP JP2020543492A patent/JP2021513972A/ja active Pending
- 2019-02-15 WO PCT/US2019/018263 patent/WO2019161236A1/en not_active Ceased
- 2019-02-15 US US16/970,089 patent/US20210008030A1/en not_active Abandoned
-
2023
- 2023-03-29 US US18/192,234 patent/US20240050401A1/en not_active Abandoned
- 2023-11-24 JP JP2023198772A patent/JP2024023383A/ja active Pending
-
2024
- 2024-12-19 US US18/987,706 patent/US20250302800A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021513972A5 (https=) | ||
| JP2006526031A5 (https=) | ||
| JP2007530694A5 (https=) | ||
| JP2020500862A5 (https=) | ||
| CN113365998A (zh) | 用于parp抑制剂的吲哚并七元酰肟类似物 | |
| JP2020097577A5 (https=) | ||
| EA202092169A1 (ru) | ПРИМЕНЕНИЕ ЗАМЕЩЕННЫХ АМИНОПРОПИОНАТНЫХ СОЕДИНЕНИЙ В ЛЕЧЕНИИ ИНФЕКЦИИ SARS-CoV-2 | |
| JP2010077141A5 (https=) | ||
| JP2014500861A5 (https=) | ||
| JP2004526788A5 (https=) | ||
| PH12014500937A1 (en) | 5-ht 1a receptor substype agonist | |
| EA202092168A1 (ru) | Применение фавипиравира в лечении коронавирусной инфекции | |
| CN113784963A (zh) | 用作ret激酶抑制剂的化合物及其应用 | |
| JP2015502974A5 (https=) | ||
| JP2011527332A5 (https=) | ||
| JP2011527333A5 (https=) | ||
| EP2639229A3 (en) | Thiazole Derivative and use thereof as VAP-1 Inhibitor | |
| JP2020507589A5 (https=) | ||
| JP2019151627A5 (https=) | ||
| JP2021530541A5 (https=) | ||
| JP2023143940A5 (https=) | ||
| MX2009009445A (es) | Derivados novedosos de benzamida y proceso para la preparacion de los mismos. | |
| JPWO2019161236A5 (https=) | ||
| IL276311B1 (en) | Methyllactam ring compound and its pharmaceutical use | |
| JP2007510741A5 (https=) |